[{"source": "benzinga", "link": "https://www.benzinga.com/general/entertainment/22/03/26065020/is-paramount-global-looking-for-a-buyer", "title": "Is Paramount Global Looking For A Buyer?", "date": "2022-03-09 12:45", "summary": "Paramount Global (NASDAQ: PARAA) CEO Bob Bakish has offered comments that give the impression his company, formerly known as ViacomCBS, would be open to being acquired.", "tickers": ["AAPL", "AMZN", "CMCSA", "DIS", "PARAA"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Is Paramount Global Looking For A Buyer?. Paramount Global (NASDAQ: PARAA) CEO Bob Bakish has offered comments that give the impression his company, formerly known as ViacomCBS, would be open to being acquired.\"\n\nStock Prediction(s) for AAPL, AMZN, CMCSA, DIS, PARAA:", "Prediction": "\n- Apple Inc. (NASDAQ: AAPL) will increase because they are a potential buyer for Paramount Global.\n- Amazon.com, Inc. (NASDAQ: AMZN) will increase because they are a potential buyer for Paramount Global.\n- Comcast Corporation (NASDAQ: CMCSA) will increase because they are a potential buyer for Paramount Global.\n- The Walt Disney Company (NYSE: DIS) will increase because they are a potential buyer for Paramount Global.\n- Paramount Global (NASDAQ: PARAA) will increase because they are a potential buyer for themselves."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/26064677/draftkings-ceo-jason-robins-has-a-warning-for-those-selling-the-stock", "title": "DraftKings CEO Jason Robins Has A Warning For Those Selling The Stock", "date": "2022-03-09 12:21", "summary": "The CEO of a leading publicly-traded sports betting company has a warning for investors thinking of selling shares near the\u00a052-week low.", "tickers": ["AAPL", "DKNG", "TWTR"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"DraftKings CEO Jason Robins Has A Warning For Those Selling The Stock. The CEO of a leading publicly-traded sports betting company has a warning for investors thinking of selling shares near the\u00a052-week low.\"\n\nStock Prediction(s) for AAPL, DKNG, TWTR:", "Prediction": "\n- Apple Inc. (NASDAQ: AAPL) will increase because the CEO of a leading publicly-traded sports betting company has a warning for investors thinking of selling shares near the 52-week low.\n- DraftKings Inc. (NASDAQ: DKNG) will increase because the CEO of a leading publicly-traded sports betting company has a warning for investors thinking of selling shares near the 52-week low.\n- Twitter, Inc. (NYSE: TWTR) will decrease because the CEO of a leading publicly-traded sports betting company has a warning for investors thinking of selling shares near the 52-week"}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/analyst-color/22/03/26064595/gene-munster-apple-is-a-250-stock-longer-term-but-this-faang-name-offers-near-term-", "title": "Gene Munster: 'Apple Is A $250 Stock' Longer Term, But This FAANG Name Offers Near-Term Upside", "date": "2022-03-09 12:17", "summary": "Apple Inc (NASDAQ: AAPL) investors focused on underwhelming product announcements at Cupertino&#39;s\u00a0&#34;Peek Performance&#34; event\u00a0Tues", "tickers": ["AAPL", "FB"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Gene Munster: 'Apple Is A $250 Stock' Longer Term, But This FAANG Name Offers Near-Term Upside. Apple Inc (NASDAQ: AAPL) investors focused on underwhelming product announcements at Cupertino&#39;s\u00a0&#34;Peek Performance&#34; event\u00a0Tues\"\n\nStock Prediction(s) for AAPL, FB:", "Prediction": "\n- Apple Inc (NASDAQ: AAPL) will increase because Gene Munster is a long-term investor and he still believes in the company.\n- Facebook Inc (NASDAQ: FB) will increase because they are not releasing any new products this year, and investors will shift their money to the social media giant."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/technicals/22/03/26062502/how-will-apple-stock-react-following-peek-performance-product-launch", "title": "How Will Apple Stock React Following 'Peek Performance' Product Launch?", "date": "2022-03-09 10:36", "summary": "Apple, Inc (NASDAQ: AAPL) was trading over 2% higher in the premarket on the day following its \u201cPeek Performance\u201d launch event, where the company unveiled a number of ", "tickers": ["AAPL", "SPY"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"How Will Apple Stock React Following 'Peek Performance' Product Launch?. Apple, Inc (NASDAQ: AAPL) was trading over 2% higher in the premarket on the day following its \u201cPeek Performance\u201d launch event, where the company unveiled a number of \"\n\nStock Prediction(s) for AAPL, SPY:", "Prediction": "\n- Apple, Inc (NASDAQ: AAPL) will continue to increase because they have a new product that is outperforming.\n- The S&P 500 (NYSE: SPY) will continue to increase because the market is bullish on Apple."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/26068391/this-ceo-has-bought-more-than-1b-of-his-own-stock-in-the-last-year", "title": "This CEO Has Been Buying More Than $1B Of His Own Stock Over The Last Year", "date": "2022-03-09 15:44", "summary": "Dustin Moskovitz co-founded Meta Platforms Inc (NASDAQ: FB) with Mark Zuckerberg at Harvard in 2004.", "tickers": ["ASAN", "FB"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"This CEO Has Been Buying More Than $1B Of His Own Stock Over The Last Year. Dustin Moskovitz co-founded Meta Platforms Inc (NASDAQ: FB) with Mark Zuckerberg at Harvard in 2004.\"\n\nStock Prediction(s) for ASAN, FB:", "Prediction": "\n- Asana Inc (NASDAQ: ASAN) will increase because the CEO is buying stock, and he is a major shareholder.\n- Facebook Inc (NASDAQ: FB) will increase because the CEO is buying stock, and he is a major shareholder."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/cryptocurrency/22/03/26068963/why-facebook-meta-platforms-twitter-and-snap-shares-are-rising-today", "title": "Why Facebook (Meta Platforms), Twitter And Snap Shares Are Rising Today", "date": "2022-03-09 15:10", "summary": "Shares of social media companies, including\u00a0Meta Platforms Inc (NASDAQ: FB),\u00a0Twitter Inc (NYSE: TWTR) and\u00a0Snap Inc (NYSE: SNA", "tickers": ["FB", "SNAP", "TWTR"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Why Facebook (Meta Platforms), Twitter And Snap Shares Are Rising Today. Shares of social media companies, including\u00a0Meta Platforms Inc (NASDAQ: FB),\u00a0Twitter Inc (NYSE: TWTR) and\u00a0Snap Inc (NYSE: SNA\"\n\nStock Prediction(s) for FB, SNAP, TWTR:", "Prediction": "\n- Facebook (Meta Platforms) will continue to rise because they are a social media company and their platform is being used more and more.\n- Snap Inc (NYSE: SNA) will continue to rise because they are a social media company and their platform is being used more and more.\n- Twitter Inc (NYSE: TWTR) will continue to rise because they are a social media company and their platform is being used more and more."}, {"source": "benzinga", "link": "https://www.benzinga.com/government/22/03/26061914/tiktok-is-having-a-hard-time-coping-up-with-russia-ukraine-crisis", "title": "TikTok Is Having A Hard Time Coping Up With Russia-Ukraine Crisis", "date": "2022-03-09 11:28", "summary": "\n\tByteDance Ltd&#39;s\u00a0TikTok grappled internally amid aggravating tensions between Russia and Ukraine,\u00a0the Wall Street Journal reports.\n", "tickers": ["FB"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"TikTok Is Having A Hard Time Coping Up With Russia-Ukraine Crisis. \n\tByteDance Ltd&#39;s\u00a0TikTok grappled internally amid aggravating tensions between Russia and Ukraine,\u00a0the Wall Street Journal reports.\n\"\n\nStock Prediction(s) for FB:", "Prediction": "\n- Facebook, Inc. (NASDAQ: FB) will increase because they are not as directly affected by the Russia-Ukraine crisis."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/long-ideas/22/03/26054662/cnbcs-final-trades-kinder-morgan-paypal-holdings-meta-platforms-and-more", "title": "CNBC's Final Trades: Kinder Morgan, PayPal Holdings, Meta Platforms And More", "date": "2022-03-09 08:54", "summary": "On CNBC\u2019s \u201cHalftime Report Final Trades,\u201d Bryn Talkington of Requisite Capital Management said Grayscale Bitcoin Trust (OTC: GBTC) was trading at a 30% discount to Bitcoin.", "tickers": ["APD", "FB", "GBTC", "KMI", "PYPL"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"CNBC's Final Trades: Kinder Morgan, PayPal Holdings, Meta Platforms And More. On CNBC\u2019s \u201cHalftime Report Final Trades,\u201d Bryn Talkington of Requisite Capital Management said Grayscale Bitcoin Trust (OTC: GBTC) was trading at a 30% discount to Bitcoin.\"\n\nStock Prediction(s) for APD, FB, GBTC, KMI, PYPL:", "Prediction": "\n- Air Products and Chemicals, Inc. (NYSE: APD) will increase because they are a competitor of Kinder Morgan.\n- Facebook, Inc. (NASDAQ: FB) will increase because they are a competitor of Kinder Morgan.\n- Grayscale Bitcoin Trust (OTC: GBTC) will increase because they are a competitor of Kinder Morgan.\n- Kinder Morgan, Inc. (NYSE: KMI) will increase because they are a competitor of Kinder Morgan.\n- PayPal Holdings, Inc. (NASDAQ: PYPL) will increase because they are a competitor of Kinder Morgan."}, {"source": "benzinga", "link": "https://www.benzinga.com/general/entertainment/22/03/26029961/how-much-money-does-mrbeast-make-from-his-youtube-videos", "title": "How Much Money Does MrBeast Make From His YouTube Videos?", "date": "2022-03-09 12:50", "summary": "Best known as MrBeast, Jimmy Donaldson is one of the most popular YouTube entertainers and regularly gets tens of millions of views on his videos.\n\nHere\u2019s a look at how MrBeast makes money and how much income he generates.", "tickers": ["COIN", "GOOG", "GOOGL", "NFLX"], "sentiments": [0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"How Much Money Does MrBeast Make From His YouTube Videos?. Best known as MrBeast, Jimmy Donaldson is one of the most popular YouTube entertainers and regularly gets tens of millions of views on his videos.\n\nHere\u2019s a look at how MrBeast makes money and how much income he generates.\"\n\nStock Prediction(s) for COIN, GOOG, GOOGL, NFLX:", "Prediction": "\n- Coinbase Inc (NASDAQ: COIN) will increase because they are a direct competitor of YouTube and they offer a similar service.\n- Alphabet Inc (NASDAQ: GOOG) will increase because they are a direct competitor of YouTube and they offer a similar service.\n- Alphabet Inc (NASDAQ: GOOGL) will increase because they are a direct competitor of YouTube and they offer a similar service.\n- Netflix, Inc. (NASDAQ: NFLX) will increase because they are a direct competitor of YouTube and they offer a similar service."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/22/03/26062366/this-foreboding-sign-looms-over-alphabets-chart", "title": "This Foreboding Sign Looms Over Alphabet's Chart", "date": "2022-03-09 10:27", "summary": "If history is any guide, there may be trouble ahead for shares of Alphabet (NASDAQ:GOOGL).  A so-called &#34;death cross&#34; has formed on its chart and, not surprisingly, this could be bearish for the stock.", "tickers": ["GOOGL"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"This Foreboding Sign Looms Over Alphabet's Chart. If history is any guide, there may be trouble ahead for shares of Alphabet (NASDAQ:GOOGL).  A so-called &#34;death cross&#34; has formed on its chart and, not surprisingly, this could be bearish for the stock.\"\n\nStock Prediction(s) for GOOGL:", "Prediction": "\n- Alphabet Inc (NASDAQ: GOOGL) will decrease because of the so-called \"death cross\" on their chart."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/26060808/adaptive-biotechnologies-to-lay-off-12-of-its-workforce-names-tycho-peterson-as-cfo", "title": "Adaptive Biotechnologies To Lay Off ~12% Of Its Workforce, Names Tycho Peterson As CFO", "date": "2022-03-09 10:37", "summary": "Adaptive Biotechnologies Corporation\u00a0(NASDAQ: ADPT) will be organized around two distinct business areas - Minimal Residual Disease (MRD) and Immune Medicine.", "tickers": ["ADPT", "MSFT"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Adaptive Biotechnologies To Lay Off ~12% Of Its Workforce, Names Tycho Peterson As CFO. Adaptive Biotechnologies Corporation\u00a0(NASDAQ: ADPT) will be organized around two distinct business areas - Minimal Residual Disease (MRD) and Immune Medicine.\"\n\nStock Prediction(s) for ADPT, MSFT:", "Prediction": "\n- Adaptive Biotechnologies Corporation (NASDAQ: ADPT) will decrease because they are downsizing their company.\n- Microsoft Corporation (NASDAQ: MSFT) will increase because they are expanding their company."}, {"source": "benzinga", "link": "https://www.benzinga.com/government/22/03/26066504/uk-considers-expanding-domestic-energy-resources-while-weaning-off-russian-oil-report", "title": "UK Considers Expanding Domestic Energy Resources While Weaning Off Russian Oil: Report", "date": "2022-03-09 13:59", "summary": "The U.K. government is scrambling to consider different domestic energy resources, including offshore drilling and fracking, in order to transition the country away from its dependence on Russian energy.", "tickers": ["SPY"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"UK Considers Expanding Domestic Energy Resources While Weaning Off Russian Oil: Report. The U.K. government is scrambling to consider different domestic energy resources, including offshore drilling and fracking, in order to transition the country away from its dependence on Russian energy.\"\n\nStock Prediction(s) for SPY:", "Prediction": "\n- The S&P 500 (NYSEARCA: SPY) will increase because the U.K. is looking to expand its domestic energy resources."}, {"source": "benzinga", "link": "https://www.benzinga.com/government/22/03/26062764/teslas-autopilot-and-fsd-capabilities-face-ire-of-lawmakers-again-all-you-need-to-know", "title": "Tesla's Autopilot and FSD Capabilities Face Ire of Lawmakers Again: All You Need To Know", "date": "2022-03-09 13:16", "summary": "Tesla Inc\u00a0(NASDAQ: TSLA) defended the safety benefits of its advanced driver assistance system Autopilot and its Full Self-Driving capability but acknowledged they require &#34;constant monitoring and attention of the driver,&#34;\u00a0", "tickers": ["TSLA"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Tesla's Autopilot and FSD Capabilities Face Ire of Lawmakers Again: All You Need To Know. Tesla Inc\u00a0(NASDAQ: TSLA) defended the safety benefits of its advanced driver assistance system Autopilot and its Full Self-Driving capability but acknowledged they require &#34;constant monitoring and attention of the driver,&#34;\u00a0\"\n\nStock Prediction(s) for TSLA:", "Prediction": "\n- Tesla's stock will continue to decrease because of the negative attention from lawmakers.\n- Other companies working on similar technology (i.e. Google, Ford, etc.) will benefit from this news."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/small-cap/22/03/26061177/a-spacex-deal-has-this-small-cap-space-stock-running-wednesday", "title": "A SpaceX Deal Has This Small-Cap Space Stock Running", "date": "2022-03-09 09:59", "summary": "A small-cap space communications company signed a agreement with one of the largest space companies Wednesday, causing shares to spike higher.", "tickers": ["AMT", "ASTS", "TSLA", "VOD"], "sentiments": [0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"A SpaceX Deal Has This Small-Cap Space Stock Running. A small-cap space communications company signed a agreement with one of the largest space companies Wednesday, causing shares to spike higher.\"\n\nStock Prediction(s) for AMT, ASTS, TSLA, VOD:", "Prediction": "\n- American Tower Corp (NYSE: AMT) will increase because they are expanding their business into the space industry.\n- Astrotech Space Operations, Inc. (NASDAQ: ASTS) will increase because they have signed an agreement with SpaceX, one of the largest space companies.\n- Tesla, Inc. (NASDAQ: TSLA) will increase because they are expanding their business into the space industry.\n- Vodafone Group Plc (NASDAQ: VOD) will increase because they are expanding their business into the space industry."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/earnings/22/03/26060928/oracle-earnings-preview", "title": "Oracle Earnings Preview", "date": "2022-03-09 09:17", "summary": "Oracle (NYSE:ORCL) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here&#39;s what investors need to know before the announcement.\nAnalysts estimate that Oracle will report an earnings per share (EPS) of $1.18. ", "tickers": ["ORCL"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Oracle Earnings Preview. Oracle (NYSE:ORCL) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here&#39;s what investors need to know before the announcement.\nAnalysts estimate that Oracle will report an earnings per share (EPS) of $1.18. \"\n\nStock Prediction(s) for ORCL:", "Prediction": "\n- Oracle Corporation (NYSE: ORCL) will increase because they are estimated to have an EPS of $1.18."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/26065465/what-are-whales-doing-with-netflix", "title": "What Are Whales Doing With Netflix", "date": "2022-03-09 12:03", "summary": "Someone with a lot of money to spend has taken a bullish stance on Netflix (NASDAQ:NFLX).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.", "tickers": ["NFLX"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"What Are Whales Doing With Netflix. Someone with a lot of money to spend has taken a bullish stance on Netflix (NASDAQ:NFLX).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.\"\n\nStock Prediction(s) for NFLX:", "Prediction": "\n- Netflix, Inc. (NASDAQ: NFLX) will continue to increase because a whale has taken a bullish stance on the company."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/analyst-color/22/03/26062286/netflix-analyst-upgrades-stock-after-longtime-bearish-stance-heres-why", "title": "Netflix Analyst Upgrades Stock After Longtime Bearish Stance: Here's Why", "date": "2022-03-09 10:51", "summary": "Netflix, Inc. (NASDAQ: NFLX) shares have come under pressure recently, and the weakness has prompted an analyst at Wedbush to upgrade the stock and take a neutral stance on it.", "tickers": ["DIS", "NFLX"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Netflix Analyst Upgrades Stock After Longtime Bearish Stance: Here's Why. Netflix, Inc. (NASDAQ: NFLX) shares have come under pressure recently, and the weakness has prompted an analyst at Wedbush to upgrade the stock and take a neutral stance on it.\"\n\nStock Prediction(s) for DIS, NFLX:", "Prediction": "\n- The Walt Disney Company (NYSE: DIS) will increase because Netflix is no longer a direct competitor, and they have other strong businesses.\n- Netflix, Inc. (NASDAQ: NFLX) will increase because the analyst upgraded the stock, and it has come down recently."}, {"source": "benzinga", "link": "https://www.benzinga.com/general/biotech/22/03/26057766/pfizers-paxlovid-becomes-first-oral-covid-19-therapy-to-be-evaluated-in-pediatric-clinical-study", "title": "Pfizer's Paxlovid Becomes First Oral COVID-19 Therapy To Be Evaluated In Pediatric Clinical Study", "date": "2022-03-09 12:10", "summary": "Pfizer Inc\u00a0(NYSE:\u00a0PFE) has initiated a Phase 2/3 EPIC-PEDS trial to evaluate Paxlovid (nirmatrelvir and ritonavir tablets)\u00a0", "tickers": ["PFE"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Pfizer's Paxlovid Becomes First Oral COVID-19 Therapy To Be Evaluated In Pediatric Clinical Study. Pfizer Inc\u00a0(NYSE:\u00a0PFE) has initiated a Phase 2/3 EPIC-PEDS trial to evaluate Paxlovid (nirmatrelvir and ritonavir tablets)\u00a0\"\n\nStock Prediction(s) for PFE:", "Prediction": "\n- Pfizer Inc (NYSE: PFE) will increase because they are the first company to initiate a pediatric clinical study for their COVID-19 therapy.\n- Other companies will initiate similar studies, but Pfizer will be the first to complete them and receive FDA approval.\n- Paxlovid will become a blockbuster drug and will contribute significantly to Pfizer's profits."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/long-ideas/22/03/26065286/exxon-mobil-stock-starts-cooling-off-a-technical-analysis", "title": "Exxon Mobil Stock Starts Cooling Off: A Technical Analysis", "date": "2022-03-09 15:51", "summary": "Exxon Mobil Corp. (NYSE: XOM) shares are trading lower Wednesday as oil prices pull back following recent strength. Oil stocks\u00a0have been gaining in recent weeks as a result of the Russia-Ukraine conflict and a resulting U.S. ban on Russian oil imports.", "tickers": ["XOM"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Exxon Mobil Stock Starts Cooling Off: A Technical Analysis. Exxon Mobil Corp. (NYSE: XOM) shares are trading lower Wednesday as oil prices pull back following recent strength. Oil stocks\u00a0have been gaining in recent weeks as a result of the Russia-Ukraine conflict and a resulting U.S. ban on Russian oil imports.\"\n\nStock Prediction(s) for XOM:", "Prediction": "\n- Exxon Mobil Corp. (NYSE: XOM) will continue to trade lower because of the Russia-Ukraine conflict and the resulting U.S. ban on Russian oil imports."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/cryptocurrency/22/03/26069114/why-exxon-mobil-diamondback-energy-and-marathon-oil-shares-are-falling-today", "title": "Why Exxon Mobil, Diamondback Energy And Marathon Oil Shares Are Falling Today", "date": "2022-03-09 15:39", "summary": "Shares of energy companies, including\u00a0Exxon Mobil Corp (NYSE: XOM),\u00a0Diamondback Energy Inc (NASDAQ: FANG) and\u00a0Marathon Oil Corporation (NYSE: ", "tickers": ["FANG", "MRO", "XOM"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Why Exxon Mobil, Diamondback Energy And Marathon Oil Shares Are Falling Today. Shares of energy companies, including\u00a0Exxon Mobil Corp (NYSE: XOM),\u00a0Diamondback Energy Inc (NASDAQ: FANG) and\u00a0Marathon Oil Corporation (NYSE: \"\n\nStock Prediction(s) for FANG, MRO, XOM:", "Prediction": "\n- Diamondback Energy Inc (NASDAQ: FANG) will increase because their competitor, Marathon Oil, is dropping.\n- Marathon Oil Corporation (NYSE: MRO) will decrease because their competitor, Diamondback Energy, is increasing.\n- Exxon Mobil Corp (NYSE: XOM) will decrease because their competitor, Diamondback Energy, is increasing."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/26068377/exxon-mobil-whale-trades-for-march-09", "title": "Exxon Mobil Whale Trades For March 09", "date": "2022-03-09 14:53", "summary": "Someone with a lot of money to spend has taken a bearish stance on Exxon Mobil (NYSE:XOM).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.", "tickers": ["XOM"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Exxon Mobil Whale Trades For March 09. Someone with a lot of money to spend has taken a bearish stance on Exxon Mobil (NYSE:XOM).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.\"\n\nStock Prediction(s) for XOM:", "Prediction": "\n- Exxon Mobil Corporation (NYSE: XOM) will decrease because a large investor is bearish on the stock."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/26054689/rivian-failed-to-disclose-price-hike-plans-to-investors-lawsuit-alleges", "title": "Rivian Failed To Disclose Price Hike Plans To Investors, Lawsuit Alleges", "date": "2022-03-09 06:48", "summary": "Rivian Automotive Inc\u00a0(NASDAQ:\u00a0RIVN) may have rolled back price hikes after widespread online backlash, but that episode has now drawn a shareholder lawsuit, protocol.com\u00a0reported\u00a0", "tickers": ["AMZN", "F", "RIVN"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Rivian Failed To Disclose Price Hike Plans To Investors, Lawsuit Alleges. Rivian Automotive Inc\u00a0(NASDAQ:\u00a0RIVN) may have rolled back price hikes after widespread online backlash, but that episode has now drawn a shareholder lawsuit, protocol.com\u00a0reported\u00a0\"\n\nStock Prediction(s) for AMZN, F, RIVN:", "Prediction": "\n- Amazon.com, Inc. (NASDAQ: AMZN) will increase because Rivian Automotive Inc (NASDAQ: RIVN) is a direct competitor, and Amazon is known for their competitive edge.\n- Ford Motor Company (NYSE: F) will increase because Rivian Automotive Inc (NASDAQ: RIVN) is a direct competitor, and Ford is known for their competitive edge.\n- Rivian Automotive Inc (NASDAQ: RIVN) will decrease because they failed to disclose price hike plans to investors, and they may have rolled back price hikes after widespread online backlash."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/asia/22/03/26055091/nickel-markets-hit-pause-as-china-also-suspends-trading-after-manic-surge-in-prices", "title": "Nickel Markets Hit Pause As China Also Suspends Trading After Manic Surge In Prices", "date": "2022-03-09 04:14", "summary": "Shanghai Futures Exchange,\u00a0China\u2019s top commodity bourse, has paused nickel trading after prices hit their upper limit, a day after a similar surge prompted the\u00a0London Metal Exchange\u00a0to take similar action, Bloomberg News\u00a0", "tickers": ["F", "GM", "TSLA"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Nickel Markets Hit Pause As China Also Suspends Trading After Manic Surge In Prices. Shanghai Futures Exchange,\u00a0China\u2019s top commodity bourse, has paused nickel trading after prices hit their upper limit, a day after a similar surge prompted the\u00a0London Metal Exchange\u00a0to take similar action, Bloomberg News\u00a0\"\n\nStock Prediction(s) for F, GM, TSLA:", "Prediction": "\n- Ford Motor Company (NYSE: F) will increase because the price of nickel is going up, and they use nickel in their production.\n- General Motors Company (NYSE: GM) will increase because the price of nickel is going up, and they use nickel in their production.\n- Tesla, Inc. (NASDAQ: TSLA) will decrease because the price of nickel is going down, and they use nickel in their production."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/analyst-color/22/03/26054361/ark-analyst-sees-bad-time-for-inefficient-ev-makers-that-use-lithium-ion-batteries-", "title": "ARK Analyst Sees 'Bad Time' For Inefficient EV Makers That Use Lithium-Ion Batteries: Here's Why", "date": "2022-03-09 02:09", "summary": "Tesla Inc\u00a0(NASDAQ:\u00a0TSLA) bull\u00a0Ark\u00a0Invest\u00a0has predicted that electric vehicle makers without enough mechanical efficiency are going to have a \u201cbad time\u201d producing cars with desirable ranges powered by lithium iron phosphate batteries (LF", "tickers": ["F", "GM", "TSLA"], "sentiments": [0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"ARK Analyst Sees 'Bad Time' For Inefficient EV Makers That Use Lithium-Ion Batteries: Here's Why. Tesla Inc\u00a0(NASDAQ:\u00a0TSLA) bull\u00a0Ark\u00a0Invest\u00a0has predicted that electric vehicle makers without enough mechanical efficiency are going to have a \u201cbad time\u201d producing cars with desirable ranges powered by lithium iron phosphate batteries (LF\"\n\nStock Prediction(s) for F, GM, TSLA:", "Prediction": "\n- Ford Motor Company (NYSE: F) will increase because they are efficient and have a desirable range.\n- General Motors Company (NYSE: GM) will decrease because they are not as efficient as Ford, and they also do not have as desirable a range.\n- Tesla Inc (NASDAQ: TSLA) will decrease because they are not as efficient as Ford, and they also do not have as desirable a range."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/26065457/check-out-what-whales-are-doing-with-uber", "title": "Check Out What Whales Are Doing With UBER", "date": "2022-03-09 12:02", "summary": "Someone with a lot of money to spend has taken a bearish stance on Uber Technologies (NYSE:UBER).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.", "tickers": ["UBER"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Check Out What Whales Are Doing With UBER. Someone with a lot of money to spend has taken a bearish stance on Uber Technologies (NYSE:UBER).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.\"\n\nStock Prediction(s) for UBER:", "Prediction": "\n- Uber Technologies (NYSE:UBER) will decrease because a large investor has taken a bearish stance on the company."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/26067328/check-out-what-whales-are-doing-with-intc", "title": "Check Out What Whales Are Doing With INTC", "date": "2022-03-09 13:35", "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Intel.\nLooking at options history for Intel (NASDAQ:INTC) we detected 22 strange trades.", "tickers": ["INTC"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Check Out What Whales Are Doing With INTC. A whale with a lot of money to spend has taken a noticeably bearish stance on Intel.\nLooking at options history for Intel (NASDAQ:INTC) we detected 22 strange trades.\"\n\nStock Prediction(s) for INTC:", "Prediction": "\n- Intel Corporation (NASDAQ: INTC) will decrease because a whale has taken a bearish stance on the company."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/analyst-color/22/03/26054927/apples-next-macbook-air-to-feature-more-color-options-but-those-rooting-for-m2-chip", "title": "Apple's Next MacBook Air To Feature More Color Options But Those Rooting For M2 Chip In For Disappointment, Says Analyst", "date": "2022-03-09 02:39", "summary": "Apple Inc. (NASDAQ: AAPL) upcoming MacBook Air will feature an all-new form factor and additional color options, but will come with an M1 chip, according to Apple analyst Ming-Chi Kuo.", "tickers": ["AAPL", "INTC"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Apple's Next MacBook Air To Feature More Color Options But Those Rooting For M2 Chip In For Disappointment, Says Analyst. Apple Inc. (NASDAQ: AAPL) upcoming MacBook Air will feature an all-new form factor and additional color options, but will come with an M1 chip, according to Apple analyst Ming-Chi Kuo.\"\n\nStock Prediction(s) for AAPL, INTC:", "Prediction": "\n- Apple Inc. (NASDAQ: AAPL) will increase because they are releasing a new MacBook Air that will feature more color options and an M1 chip.\n- Intel Corporation (NASDAQ: INTC) will decrease because they are not releasing a new product and they are a direct competitor of Apple."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/price-target/22/03/26067029/why-palantir-shares-are-ripping-higher", "title": "Why Palantir Shares Are Ripping Higher", "date": "2022-03-09 13:25", "summary": "Palantir Technologies Inc (NYSE: PLTR) is surging\u00a0Wednesday after\u00a0Piper Sandler analyst Weston Twigg\u00a0initiated coverage on the stock with an Overweight rating and a $15 price target.", "tickers": ["PLTR"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Why Palantir Shares Are Ripping Higher. Palantir Technologies Inc (NYSE: PLTR) is surging\u00a0Wednesday after\u00a0Piper Sandler analyst Weston Twigg\u00a0initiated coverage on the stock with an Overweight rating and a $15 price target.\"\n\nStock Prediction(s) for PLTR:", "Prediction": "\n- Palantir Technologies Inc (NYSE: PLTR) will continue to surge because they have a new analyst that has given them an Overweight rating."}, {"source": "benzinga", "link": "https://www.benzinga.com/analyst-ratings/analyst-color/22/03/26060455/why-this-data-analytics-companys-high-growth-will-likely-continue", "title": "Why This Data Analytics Company's 'High Growth' Will Likely Continue", "date": "2022-03-09 09:24", "summary": "Palantir Technologies Inc. (NYSE: PLTR), while being controversial, has set its sights on achievable growth targets, according to an analyst at Piper Sandler.", "tickers": ["PLTR"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Why This Data Analytics Company's 'High Growth' Will Likely Continue. Palantir Technologies Inc. (NYSE: PLTR), while being controversial, has set its sights on achievable growth targets, according to an analyst at Piper Sandler.\"\n\nStock Prediction(s) for PLTR:", "Prediction": "\n- Palantir Technologies Inc. (NYSE: PLTR) will continue to grow because they have set achievable goals."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/26066722/what-are-whales-doing-with-united-states-steel", "title": "What Are Whales Doing With United States Steel", "date": "2022-03-09 13:02", "summary": "Someone with a lot of money to spend has taken a bearish stance on United States Steel (NYSE:X).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.", "tickers": ["X"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"What Are Whales Doing With United States Steel. Someone with a lot of money to spend has taken a bearish stance on United States Steel (NYSE:X).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.\"\n\nStock Prediction(s) for X:", "Prediction": "\n- United States Steel (NYSE:X) will continue to decrease because someone is bearish on the stock and is betting against it."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/cryptocurrency/22/03/26032483/amc-chief-says-there-has-been-immediate-benefit-to-businesss-from-enabling-crypto-payments", "title": "AMC Chief Says There Has Been 'Immediate Benefit' To Business From Enabling Crypto Payments", "date": "2022-03-08 21:32", "summary": "AMC Entertainment Holdings Inc. (NYSE: AMC) CEO Adam Aron said that the movie theater chain has already seen a benefit from accepting cryptocurrencies such as Bitcoin (", "tickers": ["AMC", "BTCUSD", "DOGEUSD", "ETHUSD", "SHIBUSD"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"AMC Chief Says There Has Been 'Immediate Benefit' To Business From Enabling Crypto Payments. AMC Entertainment Holdings Inc. (NYSE: AMC) CEO Adam Aron said that the movie theater chain has already seen a benefit from accepting cryptocurrencies such as Bitcoin (\"\n\nStock Prediction(s) for AMC, BTCUSD, DOGEUSD, ETHUSD, SHIBUSD:", "Prediction": "\n- AMC Entertainment Holdings Inc. (NYSE: AMC) will increase because they are accepting cryptocurrencies, and this will bring in new customers.\n- Bitcoin (BTCUSD) will increase because AMC is accepting it, and this will bring in new customers.\n- Dogecoin (DOGEUSD) will increase because AMC is accepting it, and this will bring in new customers.\n- Ethereum (ETHUSD) will increase because AMC is accepting it, and this will bring in new customers.\n- Shibuya (SHIBUSD) will increase because AMC is accepting it, and this will bring in new customers."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/technicals/22/03/26068627/chart-wars-between-snap-and-pinterest-which-stock-is-less-risky", "title": "Chart Wars: Between Snap And Pinterest, Which Stock Is Less Risky?", "date": "2022-03-09 15:32", "summary": "Snap, Inc (NYSE: SNAP) and Pinterest, Inc (NYSE: PINS) were trading 8% higher at one point\u00a0on Wednesday, as the general markets rebounded from a steep 4-day downturn during which the S&amp;P 500 declined over 5%.", "tickers": ["PINS", "SNAP"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Chart Wars: Between Snap And Pinterest, Which Stock Is Less Risky?. Snap, Inc (NYSE: SNAP) and Pinterest, Inc (NYSE: PINS) were trading 8% higher at one point\u00a0on Wednesday, as the general markets rebounded from a steep 4-day downturn during which the S&amp;P 500 declined over 5%.\"\n\nStock Prediction(s) for PINS, SNAP:", "Prediction": "\n- Pinterest, Inc (NYSE: PINS) will continue to increase because they are a less risky investment than Snap, Inc (NYSE: SNAP).\n- Snap, Inc (NYSE: SNAP) will continue to decrease because they are a more risky investment than Pinterest, Inc (NYSE: PINS)."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/26063562/check-out-what-whales-are-doing-with-general-motors", "title": "Check Out What Whales Are Doing With General Motors", "date": "2022-03-09 10:44", "summary": "A whale with a lot of money to spend has taken a noticeably bullish stance on General Motors.\nLooking at options history for General Motors (NYSE:GM) we detected 13 strange trades.", "tickers": ["GM"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Check Out What Whales Are Doing With General Motors. A whale with a lot of money to spend has taken a noticeably bullish stance on General Motors.\nLooking at options history for General Motors (NYSE:GM) we detected 13 strange trades.\"\n\nStock Prediction(s) for GM:", "Prediction": "\n- General Motors (NYSE:GM) will increase because a whale has taken a bullish stance on the company.\n- General Motors (NYSE:GM) will increase because the company is doing well overall."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/26062717/this-is-what-whales-are-betting-on-delta-air-lines", "title": "This Is What Whales Are Betting On Delta Air Lines", "date": "2022-03-09 10:43", "summary": "Someone with a lot of money to spend has taken a bullish stance on Delta Air Lines (NYSE:DAL).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.", "tickers": ["DAL"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"This Is What Whales Are Betting On Delta Air Lines. Someone with a lot of money to spend has taken a bullish stance on Delta Air Lines (NYSE:DAL).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.\"\n\nStock Prediction(s) for DAL:", "Prediction": "\n- Delta Air Lines (NYSE: DAL) will increase because a whale has taken a bullish stance on the company."}, {"source": "benzinga", "link": "https://www.benzinga.com/fintech/22/03/26031441/exclusive-how-stack-capital-gives-you-a-chance-to-invest-in-fast-growing-privates-like-spacex", "title": "EXCLUSIVE: How Stack Capital Gives You A Chance To Invest In Fast-Growing Privates Like SpaceX", "date": "2022-03-09 12:26", "summary": "For over a year, risk assets have de-rated as participants priced in the implications of contractionary monetary policies and waning stimulus.", "tickers": ["BNS", "HOOD", "RY", "SCHW", "TD"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"EXCLUSIVE: How Stack Capital Gives You A Chance To Invest In Fast-Growing Privates Like SpaceX. For over a year, risk assets have de-rated as participants priced in the implications of contractionary monetary policies and waning stimulus.\"\n\nStock Prediction(s) for BNS, HOOD, RY, SCHW, TD:", "Prediction": "\n- Bank of Nova Scotia (NYSE: BNS) will increase because they offer a unique investment opportunity in SpaceX.\n- Hooker Furniture Corporation (NASDAQ: HOOD) will increase because they offer a unique investment opportunity in SpaceX.\n- Royal Bank of Canada (NYSE: RY) will increase because they offer a unique investment opportunity in SpaceX.\n- The Charles Schwab Corporation (NYSE: SCHW) will increase because they offer a unique investment opportunity in SpaceX.\n- Toronto-Dominion Bank (NYSE: TD) will increase because they offer a unique investment opportunity in SpaceX."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/26067333/check-out-what-whales-are-doing-with-mrna", "title": "Check Out What Whales Are Doing With MRNA", "date": "2022-03-09 13:35", "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna.\nLooking at options history for Moderna (NASDAQ:MRNA) we detected 40 strange trades.", "tickers": ["MRNA"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Check Out What Whales Are Doing With MRNA. A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna.\nLooking at options history for Moderna (NASDAQ:MRNA) we detected 40 strange trades.\"\n\nStock Prediction(s) for MRNA:", "Prediction": "\n- Moderna Inc (NASDAQ: MRNA) will decrease because a whale has taken a bearish stance on the company."}, {"source": "benzinga", "link": "https://www.benzinga.com/general/health-care/22/03/26066202/chart-wars-between-moderna-and-novavax-which-covid-stock-will-soar-higher", "title": "Chart Wars: Between Moderna And Novavax, Which COVID Stock Will Soar Higher?", "date": "2022-03-09 13:11", "summary": "Moderna, Inc (NASDAQ: MRNA) and Novavax, Inc (NASDAQ: NVAX) were trading up over 10% and 8%, respectively, at one point\u00a0on Wednesday, boosted by the S&amp;P 500\u2019s almost 2.6% intraday gain.", "tickers": ["MRNA", "NVAX"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Chart Wars: Between Moderna And Novavax, Which COVID Stock Will Soar Higher?. Moderna, Inc (NASDAQ: MRNA) and Novavax, Inc (NASDAQ: NVAX) were trading up over 10% and 8%, respectively, at one point\u00a0on Wednesday, boosted by the S&amp;P 500\u2019s almost 2.6% intraday gain.\"\n\nStock Prediction(s) for MRNA, NVAX:", "Prediction": "\n- Moderna, Inc (NASDAQ: MRNA) will continue to increase because they are working on a better vaccine than Novavax.\n- Novavax, Inc (NASDAQ: NVAX) will continue to decrease because their vaccine is not as good as Moderna's."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/long-ideas/22/03/26066478/this-stock-could-easily-go-to-200-why-josh-brown-bought-moderna-shares", "title": "'This Stock Could Easily Go To $200': Why Josh Brown Bought Moderna Shares", "date": "2022-03-09 13:04", "summary": "Ritholtz Wealth Management&#39;s Josh Brown has managed to successfully\u00a0catch another falling knife\u00a0\u2014\u00a0at least short term.\u00a0", "tickers": ["MRNA"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"'This Stock Could Easily Go To $200': Why Josh Brown Bought Moderna Shares. Ritholtz Wealth Management&#39;s Josh Brown has managed to successfully\u00a0catch another falling knife\u00a0\u2014\u00a0at least short term.\u00a0\"\n\nStock Prediction(s) for MRNA:", "Prediction": "\n- Moderna Inc (NASDAQ: MRNA) will increase because they have a good product and they are being bought by Josh Brown.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are a direct competitor of AstraZeneca."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/options/22/03/26068374/amazon-com-whale-trades-for-march-09", "title": "Amazon.com Whale Trades For March 09", "date": "2022-03-09 14:53", "summary": "Someone with a lot of money to spend has taken a bearish stance on Amazon.com (NASDAQ:AMZN).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.", "tickers": ["AMZN"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Amazon.com Whale Trades For March 09. Someone with a lot of money to spend has taken a bearish stance on Amazon.com (NASDAQ:AMZN).\nAnd retail traders should know.\nWe noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.\"\n\nStock Prediction(s) for AMZN:", "Prediction": "\n- Amazon.com, Inc. (NASDAQ: AMZN) will decrease because a whale has taken a bearish stance on the company."}]